4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000101
Chief Medical Officer gave up 248 shares (to pay taxes)
- Chief Medical Officer acquired 833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gheuens Sarah Chief Medical Officer | 2022-12-02 | Option exercise | +833 | 9,261 | D: show line 1 in the form | ||
| Gheuens Sarah Chief Medical Officer | 2022-12-06 | Shares withheld for taxes | −248 | $28.83 | $7,150 | 9,013 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gheuens Sarah Chief Medical Officer | 2022-12-02 | Option exercise · Restricted stock units | −833 | 0 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_167036124284100.xml…